Skip to main content
. 2021 Apr 12;12:665147. doi: 10.3389/fimmu.2021.665147

Figure 1.

Figure 1

Cytokines are associated with the response of combination therapy in responder (R)/non-responder (NR) patients and patients with clinical benefit/no clinical benefit (NCB). (A) Comparison of 27 cytokines in R patients and NR patients at different time points and different ratios in the volcano map. (B) Comparison of 27 cytokines in CB and NCB patients at different time points and different ratios in the volcano map. Cytokines with a log2 |fold-change| greater than 1.0 and a −log10 (P-value) greater than 1.3 were considered significant.